Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Assistant Researcher in Immunity and Infection

Total project amount

246,79 thousand €

Amount paid

0 €

Non-refundable funding

246,79 thousand €

Loan funding

0 €

Start date

01.02.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.14140.TENURE.007

Summary

Infectious diseases pose a critical threat to global health security with high morbidity, mortality, and healthcare costs. Many infectious agents have emerged and reemerged in recent decades due to the dynamic host-pathogen interactions, partially driven by anthropogenic selection, niche adaptation and climatic and socioeconomical changes that have impacted many ecosystems. Current control measures have not been sufficient to stop those emerging and re-emerging infectious diseases. The COVID-19 pandemic is a paradigmatic example that has raised global health concerns about emerging zoonotic diseases attributable to not only viruses but also bacteria, parasites and fungi. To reduce the burden of emerging and re-emerging infectious diseases we need to urgently strengthen our capacity of investigation to fully understand the mechanisms involved in host-pathogen interactions and translate knowledge into solutions to prevent, detect and control emerging and epidemic-prone infectious diseases.The Infection, Immunity, and Regeneration (IIR) integrative program of i3S conducts fundamental and applied research into the intricate interactions between the host immune system and foreign threats or materials, including pathogens, cancer, and bioengineered materials. Our collaborative environment fosters innovation and transdisciplinary research, with a primary aim of advancing knowledge in infection, immune response and tissue regeneration.The scientific strategy driving the need for this Assistant Researcher position is to construct a diverse team of Staff Scientists, strengthening multidisciplinary collaborative projects within the Infection and Immunity research area of the program.In particular, given the importance of this area of research for human health, as well as for the IIR Program, we want to reinforce our critical mass and increase our international competitiveness in the identification and comprehension of: virulence mechanisms of pathogens; molecular and cellular processes underlying host immune responses; and mechanisms of microbe-induce disease, in order to develop advanced diagnosis and anti-infective systems.Within the context of IIR research groups, candidates are expected to develop their own research projects and actively seek research funding. Additional responsibilities include promoting knowledge and technology transfer; supporting advanced training by participating in graduate and PhD programs, supervising PhD, Master and other students, and by promoting advanced training courses, increasing science awareness by participating in the i3S educational program and outreach activities and providing operational support to the laboratory.We particularly welcome applications from candidates holding a PhD in Life Sciences, Health, or related fields for over 5 years. Candidates should possess a scientifically relevant background in infection and/or immunology, demonstrating scientific excellence and autonomy through original contributions to peer-reviewed publications in high-impact journals. Moreover, candidates should have prior experience in leading research projects, securing competitive funds, supervising doctoral students, engaging in international research endeavors, and delivering lectures/presentations at national/international meetings.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

8,7
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

246,79 thousand €

Total amount of the project

Where was the money spent

By county

1 county financed .

  • Porto 246,79 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading